Latin America Point of Care Diagnostics Market worth $1.15 billion by 2031
The report "Latin America Point of Care Diagnostics Market by Product (Glucose, Infectious Disease [TB, HAI, STD], Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx [RT-PCR, INAAT]), Sample (Blood, Urine), End User (Home Care, Hospitals) - Forecast to 2031" is projected to grow from USD 0.79 billion in 2026 and to reach USD 1.15 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 7.9% during the forecast period.
Browse 210 market data Tables and 45 Figures spread through 245 Pages and in-depth TOC on "Latin America Point of Care Diagnostics Market by Product (Glucose, Infectious Disease [TB, HAI, STD], Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx [RT-PCR, INAAT]), Sample (Blood, Urine), End User (Home Care, Hospitals) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/latin-america-point-of-care-diagnostics-market-100805737.html
The Latin America point-of-care (POC) diagnostics market is experiencing rapid growth, driven by the rising incidence of chronic conditions, particularly diabetes and cardiovascular diseases. The rising prevalence of these diseases has increased demand for rapid, reliable diagnostic solutions that enable timely detection and management. Additionally, the growing availability of simpler and user-friendly POC tests has encouraged healthcare providers across the region to expand decentralized testing services. Increased government spending on public health screening programs, along with a gradual shift toward decentralized healthcare delivery models that prioritize test accessibility, are further supporting market growth. These initiatives aim to facilitate early diagnosis, provide cost-effective care, and improve population health outcomes, which continue to drive demand for point-of-care diagnostics throughout Latin America.
Prescription-based testing products accounted for the largest share of the Latin America point-of-care diagnostics market
The Latin America point-of-care diagnostics market can be categorized into over-the-counter and prescription-based testing solutions. Prescription-based tests hold a significant share of this market in the region, primarily because of their widespread use in hospital settings. The increasing prevalence of lifestyle-related diseases, such as diabetes and cardiovascular disorders, along with a rise in infectious diseases, drives the demand for prescription-based point-of-care tests. These tests are essential for accurate diagnosis and effective treatment of these conditions. Additionally, they are designed to meet clinical standards in Latin America countries, ensuring their effectiveness in diagnosing patients’ diseases accurately.
In the Latin America point-of-care diagnostics market, the home care settings and self-testing segment accounted for the largest market share
The Latin America point-of-care (POC) diagnostics market is divided into several segments based on end users. These segments include clinical laboratories, ambulatory care facilities and physicians’ offices, hospitals, critical care centers, and urgent care centers, home care settings and self-testing, and other end users. Notably, the home care settings and self-testing segment have emerged as particularly promising in the region’s POC diagnostics market. This growth can be attributed to the increasing demand for healthcare services observed over the past decade. The rise of the home care segment is largely driven by the growing need for healthcare, especially in areas experiencing a surge in chronic diseases, as many patients prefer preventive measures. Self-testing facilities have proven highly beneficial, allowing patients to monitor their health conditions without frequent visits to healthcare facilities. This approach aids in the treatment and management of chronic diseases, particularly diabetes.
The major players operating in this market are Siemens (Germany), Abbott Diagnostics (US), Danaher Corporation (US), F. Roche Ltd (Switzerland), Quidel Corporation (US), Thermo Fisher (US), Becton, Dickinson and Company (US), BIOSYNEX (France), bioMérieux (France), and EKF Diagnostics (UK).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Latin America Point of Care Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
